Access Site Complications

Chapter

Abstract

An understanding of access site complications is essential for the invasive cardiologist. Access site complications are associated with increased morbidity and all-cause mortality, and cessation of evidence-based therapies. While absolute rates of major access site complications are low, the large volume of yearly endovascular interventions means that many patients are affected by these complications despite best practices. In this chapter we review the most common complications that can occur in the catheterization laboratory by access site and outline evidence- and experience-based measures and techniques for the prevention and management of these events.

Notes

Acknowledgments

We would like to thank and acknowledge Stephen W. Waldo, MD, Ehrin J. Armstrong, MD and John C. Messenger, MD for their support, guidance and mentorship.

References

  1. 1.
    Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009. Circ Cardiovasc Qual Outcomes. 2011;4:193–7.CrossRefGoogle Scholar
  2. 2.
    Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, Chen AY, Klein LW, Masoudi FA, McKay C, Hewitt K, Brindis RG, Peterson ED, Rumsfeld JS. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56:254–63.CrossRefGoogle Scholar
  3. 3.
    Rao SV, Dai D, Subherwal S, Weintraub WS, Brindis RS, Messenger JC, Lopes RD, Peterson ED. Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. J Am Coll Cardiol Intv. 2012;5:958–65.CrossRefGoogle Scholar
  4. 4.
    Doyle B, Rihal CS, Gastineau DA, Holmes DR. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2009;53:2019–27.CrossRefGoogle Scholar
  5. 5.
    Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008;1:379–86.CrossRefGoogle Scholar
  6. 6.
    Valle et al. Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. Oct, 2017;(17)31491–7.Google Scholar
  7. 7.
    Mehran R, Rao SV, Bhatt DL, Gibson MC, Caixeta A, Eikeloom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials—a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736–47.CrossRefGoogle Scholar
  8. 8.
    The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329(10):673–82.Google Scholar
  9. 9.
    Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E, TRITON-TIMI 38 Investigators. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the Trial to assess Improvement in Therapeutic Outcomes by optimizing platelet Inhibition with prasugrel–Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006;152:627–35.CrossRefGoogle Scholar
  10. 10.
    Piper WD, Malenka DJ, Ryan TJ Jr, Shubrooks SJ Jr, O’Connor GT, Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA Jr, Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath PD, O’Mears JR, Wennberg DE, Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary interventions. Am Heart J. 2003;145:1022–9.CrossRefGoogle Scholar
  11. 11.
    Subherwal S, Peterson ED, Dai D, Thomas L, Messenger JC, Xian Y, Brindis RG, Feldman DN, Senter S, Klein LW, Marso SP, Roe MT, Rao SV. Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2012;59:1861–9.CrossRefGoogle Scholar
  12. 12.
    Applegate R, Sacrinty M, Kutcher M, Kahl F, Gandhi S, Santos R, Little W. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008;1:317–26.CrossRefGoogle Scholar
  13. 13.
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44–122.CrossRefGoogle Scholar
  14. 14.
    Trimarchi S, Smith DE, Share D, Jani SM, O’Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M, BMC2 Registry. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality. J Am Coll Cardiol Intv. 2010;3:845–50.CrossRefGoogle Scholar
  15. 15.
    Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, Cohen DJ, Messenger JC, Rumsfeld JS. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. J Am Med Assoc. 2010;303:2156–64.CrossRefGoogle Scholar
  16. 16.
    Sobolev M, Slovut DP, Lee Chang A, Shiloh AL, Eisen LA. Ultrasound-guided catheterization of the femoral artery: a systematic review and meta-analysis of randomized controlled trials. J Invasive Cardiol. 2015;27:318–23.PubMedGoogle Scholar
  17. 17.
    Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, Suh WM, Vera JA, Aston CE, Winters RJ, Patel PM, Hennebry TA, Kern MJ. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access with Ultrasound Trial). JACC Cardiovasc Interv. 2010;3:751–8.CrossRefGoogle Scholar
  18. 18.
    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358(21):2218–30.CrossRefGoogle Scholar
  19. 19.
    Steg PG, van’t Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo Dell’ Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013;369(23):2207–17.CrossRefGoogle Scholar
  20. 20.
    Stone GW, Mehran R, Goldstein P, Witzenbichler B, Van't Hof A, Guagliumi G, Hamm CW, Généreux P, Clemmensen P, Pocock SJ, Gersh BJ, Bernstein D, Deliargyris EN, Steg PG. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. J Am Coll Cardiol. 2015;65:27–38.CrossRefGoogle Scholar
  21. 21.
    Shahzad A, Kemp I, Mars C, Wilson K, Roome C, Cooper R, Andron M, Appleby C, Fisher M, Khand A, Kunadian B, Mills JD, Morris JL, Morrison WL, Munir S, Palmer ND, Perry RA, Ramsdale DR, Velavan P, Stables RH. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised, controlled trial. Lancet. 2014;384:1849–58.CrossRefGoogle Scholar
  22. 22.
    Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. Journal Am Med Assoc. 2015;313:1336–46.CrossRefGoogle Scholar
  23. 23.
    Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochrane Database Syst Rev. 2016;(3):CD009541.Google Scholar
  24. 24.
    Webber GW, Jang J, Gustavson S, Olin JW. Contemporary mangement of postcatheterization pseudoaneurysms. Circulation. 2007;115:2666–74.CrossRefGoogle Scholar
  25. 25.
    Kent KC, McArdle CR, Kennedy B, Baim DS, Anninos E, Skillman JJ. A prospective study of the clinical outcome of femoral pseudoaneurysms and arteriovenous fistulas induced by arterial puncture. J Vasc Surg. 1993;17:125–31.CrossRefGoogle Scholar
  26. 26.
    Perings SM, Kelm M, Jax T, Strauer BE. A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization. Int J Cardiol. 2003;88:223–8.CrossRefGoogle Scholar
  27. 27.
    Kelm M, Perings SM, Jax T, Lauer T, Schoebel FC, Heintzen MP, Perings C, Strauer BE. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol. 2002;40:291–7.CrossRefGoogle Scholar
  28. 28.
    Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol. 1998;21:361–6.CrossRefGoogle Scholar
  29. 29.
    Samore MH, Wessolossky MA, Lewis SM, Shubrooks SJ Jr, Karchmer AW. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1997;79:873–7.CrossRefGoogle Scholar
  30. 30.
    Muñoz P, Blanco JR, Rodríguez-Creixéms M, García E, Delcan JL, Bouza E. Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med. 2001;161:2110–5.CrossRefGoogle Scholar
  31. 31.
    Vidi VD, Matheny ME, Govindarajulu US, Normand SL, Robbins SL, Agarwal VV, Bangalore S, Resnic FS. Vascular closure device failure in contemporary practice. J Am Coll Cardiol Intv. 2012;5:837–44.CrossRefGoogle Scholar
  32. 32.
    Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005;80:1011–5.CrossRefGoogle Scholar
  33. 33.
    Feldman DN, Swaminathan RV, Kaltenbach LA, Baklanov DV, Kim LK, Wong SC, Minutello RM, Messenger JC, Moussa I, Garratt KN, Piana RN, Hillegass WB, Cohen MG, Gilchrist IC, Rao SV. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the National Cardiovascular Data Registry (2007–2012). Circulation. 2013;127:2295–306.CrossRefGoogle Scholar
  34. 34.
    Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet. 2011;377:1409–20.CrossRefGoogle Scholar
  35. 35.
    Tizón-Marcos H, Barbeau GR. Incidence of compartment syndrome of the arm in a large series of transradial approach for coronary procedures. J Interv Cardiol. 2008;21:380–4.CrossRefGoogle Scholar
  36. 36.
    Kotowycz MA, Dzavík V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012;5:127–33.CrossRefGoogle Scholar
  37. 37.
    Williams PD, Mamas MA, Fraser DG. Recanalization of a chronic radial artery occlusion allowing subsequent complex coronary intervention. Circ Cardiovasc Interv. 2012;5:e34–6.CrossRefGoogle Scholar
  38. 38.
    Ruzsa Z, Pintér L, Kolvenbach R. Anterograde recanalisation of the radial artery followed by transradial angioplasty. Cardiovasc Revasc Med. 2010;11:266e1–4.CrossRefGoogle Scholar
  39. 39.
    Kristić I, Lukenda J. Radial artery spasm during transradial coronary procedures. J Invasive Cardiol. 2011;23:527–31.PubMedGoogle Scholar
  40. 40.
    Kiemeneij F, Vajifdar BU, Eccleshall SC, Laarman G, Slagboom T, van der Wieken R. Evaluation of a spasmodic cocktail to prevent radial artery spasm during coronary procedures. Catheter Cardiovasc Interv. 2003;58:281–4.CrossRefGoogle Scholar
  41. 41.
    Collins N, Wainstein R, Bhagwandeen R, Dzavik V. Pseudoaneurysm after transradial cardiac catheterization: case series and review of the literature. Catheter Cardiovasc Interv. 2012;80:283–7.CrossRefGoogle Scholar
  42. 42.
    Zellner C, Ports TA, Yeghiazarians Y, Boyle AJ. Sterile radial artery granuloma after transradial procedures: a unique and avoidable complication. Catheter Cardiac Interv. 2010;76:673–6.CrossRefGoogle Scholar
  43. 43.
    Jang HJ, Kim JY, Han JD, Lee HJ, Kim JS, Park JS, Choi RK, Choi YJ, Shim WH, Kwon SW, Kim TH. Numbness after transradial cardiac catheterization: the results from a nerve conduction study of the superficial radial nerve. Korean Circ J. 2016;46:161–8.CrossRefGoogle Scholar
  44. 44.
    Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the ACCESS study. J Am Coll Cardiol. 1997;29:1269–75.CrossRefGoogle Scholar
  45. 45.
    Hiddick-Smith D, Khan ZI, Shapiro LM, Petch MC. Occasional-operator percutaneous brachial coronary angiography: first, do no arm. Catheter Cardiovasc Interv. 2002;57(2):161–5.CrossRefGoogle Scholar
  46. 46.
    Armstrong P, Han DC, Baxter JA, Franklin DP. Complication rates of percutaneous brachial artery access in peripheral vascular angiography. Ann Vasc Surg. 2003;17:107–10.CrossRefGoogle Scholar
  47. 47.
    Alvarez-Tostado J, Moise M, Bena J, Pavkov M, Greenberk R, Clair D, Kashyap V. The brachial artery: a critical access for endovascular procedures. J Vasc Surg. 2009;49:378–85.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Cardiology, University of Colorado School of MedicineAuroraUSA
  2. 2.Veterans Affairs Eastern Colorado Health Care SystemDenverUSA

Personalised recommendations